PURPOSE: To develop and assess an interactive continuing medical education/continuing education (CME/CE) program using adult learning concepts to educate primary care clinicians about best practices in chronic obstructive pulmonary disease (COPD).
METHODS: We applied ADDIE (Analysis, Design, Development, Implementation, Evaluation), a systematic approach to create this COPD CME/CE activity. ACCP and American Academy of Nurse Practitioners partnered to deliver this CME/CE program to primary care clinicians throughout the US. Our needs assessment (Analysis phase) identified “practice gaps” of under-diagnosis and suboptimal management of COPD. We created and linked (Design phase) learning objectives to program assessments, including self-assessment and pre-/post-questions, a “commitment-to-change” letter, and follow-up survey. We developed content using multiple educational methods based on best practices in the adult learning field, as well as, ACCP learning categories (Development phase). We created detailed faculty training programs for reproducibility and conducted the pilot program (Implementation phase). Based on observations and evaluations, we made adjustments to the content and agenda (Evaluation phase).
RESULTS: Twenty courses are scheduled through 11/10. An average of 18-20 participants attended each course. Of the completed courses, only 34% of participants reported that they were comfortable or confident managing COPD patients and 56% reported that they had not used or were not aware of the Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines prior to the course. Upon completion, 91% reported that they felt comfortable or confident managing COPD patients. In addition, knowledge and comprehension significantly improved. Participants committed to an average of 3.5 concrete changes in their practice, of which, 32% involved obtaining a spirometer or increasing its use for diagnosis, 11% involved implementing a COPD screener tool and/or questioning for earlier symptom recognition, and 24 % involved GOLD guideline implementation into clinical practice.
CONCLUSION: We created an interactive COPD CME/CE program for primary care that improved clinician confidence, knowledge, and appeared to impact changes in clinical practice.
CLINICAL IMPLICATIONS: This program can be a model for developing other CME/CE programs in pulmonary, critical care, and sleep conditions.
DISCLOSURE: Sandra Adams, Grant monies (from sources other than industry) Dr. Adams: National Institute of Health (NIH), Veterans Affairs Cooperative Studies Program;Dr. Hanania: NIH, American Lung Association;; Grant monies (from industry related sources) AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline provided unrestricted grants for these COPD CME/CE programs.Dr. Adams: Bayer Pharmaceuticals Corp; Boehringer Ingelheim Pharmaceuticals, Inc; Centocor Inc, GlaxoSmithKline; Novartis Pharmaceuticals AG; Pfizer Inc; Schering-Plough Corp;Dr. Yawn: GlaxoSmithKline, Novartis, Boehringer Ingelheim, Pfizer;Dr. Hanania: Boehringer Ingelheim, Dey Inc, GSK, Sepracor, Novartis;; Consultant fee, speaker bureau, advisory committee, etc. Dr. Hanania: GSK, Sepracor, Boerhinger Ingelheim, Nycomed, Novartis; No Product/Research Disclosure Information